In 1675, Sir Isaac Newton wrote:
"If I have seen further it is by standing
on the shoulders of giants."
In developing each mEYE® report we are relying on research conducted over many decades by thousands of researchers worldwide. Over 30,000 research papers on myopia alone are listed on PubMed®, the world's largest medical science database.
Harnessing advanced data science tools, Ocumetra translates findings from peer-reviewed research, incorporating over a million data points on refractive development, eye growth, myopia-related eye disease, and vision impairment to craft highly personalized mEYE reports for each child examined.
This part of the tool simulates expected vision quality with either glasses/contact lenses and without glasses/contact lenses (uncorrected vision). While a myopic child's vision with glasses/contact lenses should remain good, their uncorrected vision will worsen with increasing myopia. At low levels of myopia, preserving uncorrected vision quality is one of the goals of treatment to ensure a child is less dependent on their glasses/contact lenses for daily life.
All available myopia management options have been tested in clinical trials comparing them to conventional single vision glasses. We express the benefits of these treatments in terms of the probability of significant changes in glasses strength. For lower levels of myopia, we assess the risk of developing related eye diseases, and for higher levels, the risk of future visual impairment. The benefits are based on average reported outcomes from current treatments.
New options and insights into treatment effectiveness can change fairly quickly as research continues to grow. We consistently review new evidence regarding treatments including how well they work and incorporate that information if necessary into each report. Your link or QR-code will always show the most up to date treatment information.
A vast amount of research has looked at how our behaviour and lifestyle growing up, affects our eyes. We have tried to distill this into the most important messages, that can help to not only delay the onset of myopia in children but also maximize how well their chosen treatment could work for them.
For a complete list of references used in the development of our tools, please get in touch at info@ocumetra.com